125 related articles for article (PubMed ID: 1878700)
41. A multiplex PCR for improved detection of typical and atypical BCR-ABL fusion transcripts.
Burmeister T; Reinhardt R
Leuk Res; 2008 Apr; 32(4):579-85. PubMed ID: 17928051
[TBL] [Abstract][Full Text] [Related]
42. Kinetics of increasing BCR-ABL transcript numbers in chronic myeloid leukemia patients who relapse after bone marrow transplantation.
Lin F; van Rhee F; Goldman JM; Cross NC
Blood; 1996 May; 87(10):4473-8. PubMed ID: 8639810
[TBL] [Abstract][Full Text] [Related]
43. Detection of residual leukemia after bone marrow transplant for chronic myeloid leukemia: role of polymerase chain reaction in predicting relapse.
Hughes TP; Morgan GJ; Martiat P; Goldman JM
Blood; 1991 Feb; 77(4):874-8. PubMed ID: 1993225
[TBL] [Abstract][Full Text] [Related]
44. Kinetics of relapse of leukemia after bone marrow transplantation: cytogenetic follow up of patients with chronic myelogenous leukemia.
Heinze B; Arnold R; Kratt E; Bunjes D; Reess K; Plecity P; Heimpel H; Fliedner TM
Bone Marrow Transplant; 1991; 7 Suppl 2():16. PubMed ID: 1878692
[No Abstract] [Full Text] [Related]
45. Competitive polymerase chain reaction to estimate the number of BCR-ABL transcripts in chronic myeloid leukemia patients after bone marrow transplantation.
Cross NC; Feng L; Chase A; Bungey J; Hughes TP; Goldman JM
Blood; 1993 Sep; 82(6):1929-36. PubMed ID: 8400243
[TBL] [Abstract][Full Text] [Related]
46. Molecular analysis of retroviral transduction in chronic myelogenous leukemia.
Claxton D; Suh SP; Filaccio M; Ellerson D; Gaozza E; Andersson B; Brenner M; Reading C; Feinberg A; Moen R
Hum Gene Ther; 1991; 2(4):317-21. PubMed ID: 1665348
[TBL] [Abstract][Full Text] [Related]
47. The chronic myelocytic cell line K 562 contains minor (m) as well as major (M) ber/abl fusion mRNAs.
Seelig R; Schranz P; Bottner C; Neubauer A; Seelig HP; Renz M
Leukemia; 1993 Nov; 7(11):1886-7. PubMed ID: 8231257
[TBL] [Abstract][Full Text] [Related]
48. BCR-ABL transcripts are early predictors for hematological relapse in chronic myeloid leukemia after hematopoietic cell transplantation with reduced intensity conditioning.
Lange T; Deininger M; Brand R; Hegenbart U; Al-Ali H; Krahl R; Poenisch W; Uharek L; Leiblein S; Gentilini C; Petersdorf E; Storb RF; Niederwieser D
Leukemia; 2004 Sep; 18(9):1468-75. PubMed ID: 15241437
[TBL] [Abstract][Full Text] [Related]
49. bcr/abl mRNA detection following bone marrow transplantation for chronic myelogenous leukemia.
Ely P; Miller WJ
Transplantation; 1991 Dec; 52(6):1023-8. PubMed ID: 1750065
[TBL] [Abstract][Full Text] [Related]
50. Detection by polymerase chain reaction of BCR/ABL transcripts in myeloproliferative diseases at time of diagnosis and for monitoring chronic myelogenous leukaemia patients after bone marrow transplantation.
Bianchi C; Cairoli R; Marenco P; Muti G; Del Monte U; Perego RA
Eur J Cancer; 1995; 31A(2):197-201. PubMed ID: 7718325
[TBL] [Abstract][Full Text] [Related]
51. Detection of BCR-ABL transcripts in chronic myeloid leukaemia by nested PCR.
Otazú IB; Zalcberg I; Tabak DG; Seuánez HN
Leuk Res; 1999 Feb; 23(2):185-90. PubMed ID: 10071134
[TBL] [Abstract][Full Text] [Related]
52. Minimal residual disease after bone marrow transplant for chronic myeloid leukaemia detected by the polymerase chain reaction.
Cross NC; Feng L; Bungey J; Goldman JM
Leuk Lymphoma; 1993; 11 Suppl 1():39-43. PubMed ID: 8251914
[TBL] [Abstract][Full Text] [Related]
53. Detection of BCR/ABL RNA transcripts using the polymerase chain reaction is highly predictive for relapse in patients transplanted with unrelated marrow grafts for chronic myelogenous leukaemia.
Drobyski WR; Endean DJ; Klein JP; Hessner MJ
Br J Haematol; 1997 Aug; 98(2):458-66. PubMed ID: 9266951
[TBL] [Abstract][Full Text] [Related]
54. A comparison of the sensitivity of blood and bone marrow for the detection of minimal residual disease in chronic myeloid leukaemia.
Lin F; Goldman JM; Cross NC
Br J Haematol; 1994 Mar; 86(3):683-5. PubMed ID: 8043457
[TBL] [Abstract][Full Text] [Related]
55. Patterns of relapse after bone marrow transplantation for chronic myeloid leukaemia.
Frassoni F; Sessarego M; Martinelli G; Strada P; Gualandi F; Lamparelli T; Pignatti PF; Defferrari R; Fugazza G; Bacigalupo A
Bone Marrow Transplant; 1991; 7 Suppl 2():17-8. PubMed ID: 1878694
[No Abstract] [Full Text] [Related]
56. Cytogenetic follow-up after allogeneic bone marrow transplantation for Ph+ CML: update of the European Cooperative Study.
Rosti G; Zaccaria A; Testoni N; Celso B; Miggiano C; Tura S; Sessarego M; Marmont AM; Gualandi F; Francesco F
Bone Marrow Transplant; 1991; 7 Suppl 2():19. PubMed ID: 1878695
[No Abstract] [Full Text] [Related]
57. Continued therapeutic response monitoring in optimal responders with CML.
Branford S
Clin Adv Hematol Oncol; 2012 Dec; 10(12):819-21. PubMed ID: 23271354
[No Abstract] [Full Text] [Related]
58. Significance of residual leukaemia transcripts after bone marrow transplant for CML.
Hughes T; Martiat P; Morgan G; Sawyers C; Witte ON; Goldman ON
Lancet; 1990 Jan; 335(8680):50. PubMed ID: 1967352
[No Abstract] [Full Text] [Related]
59. Clinical significance of bcr-abl gene rearrangement detected by the polymerase chain reaction after allogeneic bone marrow transplantation in chronic myelogenous leukemia.
Pichert G; Ritz J
Leuk Lymphoma; 1993 May; 10(1-2):1-8. PubMed ID: 8374516
[TBL] [Abstract][Full Text] [Related]
60. Novel type of BCR-ABL transcript in a chronic myelogenous leukaemia patient relapsed after bone marrow transplantation.
Roman J; Parziale A; Gottardi E; De Micheli D; Cilloni D; Tiribelli M; Gonzalez MG; del Carmen Rodriguez M; Torres A; Saglio G
Br J Haematol; 2000 Nov; 111(2):644-6. PubMed ID: 11122114
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
